Furthermore, weight loss associated with GLP-1 administration alone often fails to meet the required weight reduction for a particular woman (249)
After achieving their goals, patients could shift to less costly weight loss medications, complemented by behavioral therapy and nutrition education
Eli Lilly developed the peptide as the next step beyond dual incretin agonists such as tirzepatide, and researchers now study it across obesity, type 2 diabetes and metabolic liver disease
Many patients read, work on their phone, or simply relax while receiving their drip
For athletes, this disrupts nutrient timing, reduces caloric intake, and can compromise both training intensity and recovery if not controlled
Nevertheless, the exact function of GLP-1RAs in the treatment of MS has not been precisely determined and demands further exploration